Skip to content

Clinical evaluation of DAILIES TOTAL 1 performance in a Japanese population.

Clinical evaluation of DAILIES TOTAL 1 performance in a Japanese population. - Clinical evaluation of DAILIES TOTAL 1 performance in a Japanese population.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000021976
Enrollment
100
Registered
2016-04-20
Start date
2016-04-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Habitual current daily disposable soft contact lenses wearers with symptoms of contact lens discomfort.

Interventions

DAILIES TOTAL 1, then 1-DAY ACUVUE TruEye 1-DAY ACUVUE TruEye, then DAILIES TOTAL 1

Sponsors

Alcon Japan Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Must sign an informed consent form; Habitual current disposable contact lenses wearer. Symptoms of contact lens discomfort as defined by the Symptomatology (Eligibility) Questionnaire. Lenses within power range specified in the protocol. Vision correctable to 0.8 or 0.1 logMAR (logarithmic minimum angle of resolution) or better in each eye at distance with pre-study contact lenses at Visit 1. Willing to wear lenses every day or at least for a minimum of 10 days, 6 hours per day, every day if possible and attend all study visits. Other protocol-specified inclusion criteria may apply.

Exclusion criteria

Exclusion criteria: Currently wearing DAILIES TOTAL 1 or 1-DAY ACUVUE TruEye sphere lenses. Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear. Use of systemic or ocular medications in which contact lens wear could be contraindicated as determined by the investigator. Eye injury or surgery within 12 weeks immediately prior to enrollment. History of herpetic keratitis, ocular surgery or irregular cornea. Prior refractive surgery. Monocular (only 1 eye with functional vision) or fit with only 1 lens. Participation in any clinical trial within 30 days of the enrollment visit. Other protocol-specified exclusion criteria may apply.

Design outcomes

Primary

MeasureTime frame
Investigator-rated successful lens centration of Optimal after 7 to 13 days of wearing.

Countries

Japan

Contacts

Public ContactMitsugu Watanabe

Alcon Japan Ltd. Phase IV, Clinical & Regulatory Affairs Division Medical Affairs

mitsugu.watanabe@alcon.com03-6899-5054

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026